Graphical representation of clinical outcomes for patients with myelodysplastic syndromes.
about
DNMT3A and TET2 in the Pre-Leukemic Phase of Hematopoietic DisordersInfographics: Healthcare Communication for the Digital AgeManagement of lower-risk myelodysplastic syndromes without del5q: current approach and future trends.A call for action: Increasing enrollment of untreated patients with higher-risk myelodysplastic syndromes in first-line clinical trials.Intensity of end-of-life care for patients with myelodysplastic syndromes: Findings from a large national database.
P2860
Graphical representation of clinical outcomes for patients with myelodysplastic syndromes.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Graphical representation of cl ...... ith myelodysplastic syndromes.
@en
type
label
Graphical representation of cl ...... ith myelodysplastic syndromes.
@en
prefLabel
Graphical representation of cl ...... ith myelodysplastic syndromes.
@en
P2860
P1433
P1476
Graphical representation of cl ...... ith myelodysplastic syndromes.
@en
P2093
David P Steensma
P2860
P356
10.3109/10428194.2015.1061191
P577
2015-06-22T00:00:00Z